Successful combination therapy for patients with platinum-resistant ovarian cancer

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2008年 / 8卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Treatment Approaches for Platinum-Resistant Ovarian Cancer
    St Laurent, Jessica
    Liu, Joyce F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (02) : 127 - 133
  • [22] Update on Strategies for Platinum-Resistant Ovarian Cancer
    Pothuri, Bhavana
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (04) : 202 - 204
  • [23] Combination therapy with Bevacizumab and GEMOX for patients with platinum-resistant recurrent ovarian cancers: A phase ll study
    Takano, M.
    Ikeda, Y.
    Oda, K.
    Kouta, H.
    Kudoh, K.
    Kita, T.
    Sasaki, N.
    Goto, T.
    Furuya, K.
    Kikuchi, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S730 - S730
  • [24] Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer
    Knisely, Anne
    Hinchcliff, Emily M.
    Gardiner, Elisabeth
    Rangwala, Reshma
    Lito, Kathryn
    Fellman, Bryan
    Yuan, Ying
    Sood, Anil K.
    Westin, Shannon N.
    Lu, Karen H.
    Jazaeri, Amir A.
    ISCIENCE, 2024, 27 (05)
  • [25] The efficacy and safety of nedaplatin single therapy in 30 patients with platinum-resistant ovarian cancer.
    Kasamatsu, Yuka
    Takekuma, Munetaka
    Kado, Nobuhiro
    Yoshioka, Emi
    Kuji, Shiho
    Tanaka, Aki
    Takahashi, Nobutaka
    Abe, Masakazu
    Hirashima, Yasuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] The outcome of patients with platinum-resistant/refractory ovarian cancer treated with the combination of pegylated liposomal doxorubicin and gemcitabine
    Galic, V.
    Boulay, R.
    Thomas, M.
    Miller, R.
    Gillenwater, C.
    Chen, C.
    Martino, M.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S48 - S48
  • [27] Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.
    Michels, Judith
    Ghiringhelli, Francois
    Frenel, Jean-Sebastien
    Brard, Caroline
    You, Benoit
    Floquet, Anne
    Eberst, Lauriane
    Bahleda, Rastilav
    Genestie, Catherine
    Balleyguier, Corinne
    Broutin, Sophie
    Pautier, Patricia
    Colomba, Emeline
    Pommeret, Fanny
    Massard, Christophe
    Marabelle, Aurelien
    Leary, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Mirvetuximab Soravtansine Improves OS in Patients With Platinum-Resistant Ovarian Cancer
    Coleman, Robert L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) : 363 - 364
  • [29] Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients
    Bruzzone, M
    Catsafados, E
    Miglietta, L
    Amoroso, D
    Pedulla, F
    Giannessi, PG
    Locatelli, MC
    DAntona, A
    Foglia, G
    Mammoliti, S
    Turno, F
    Gentile, A
    Nicosia, F
    Luporini, G
    Ragni, N
    Boccardo, F
    ONCOLOGY, 1996, 53 (05) : 349 - 353
  • [30] Homologous recombination deficiency and platinum rechallenge in platinum-resistant ovarian cancer patients.
    Da Costa, Alexandre Andre B. A.
    Salvadori, Marcela Marinelli
    Valadares, Camila Vieira
    Stecca, Carlos
    Brot, Louise
    do Canto, Luisa Matos
    Baiocchi, Glauco
    Rogatto, Silvia Regina
    Achatz, Maria Isabel Waddington
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345